A Phase II Study of Rulonilimab Combined With Chemotherapy in the First-Line Treatment for Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Correlation Between Myocardial Injury and Intestinal Flora Changes Associated With Oncology Drug Therapy and the Preventive of Probiotics
- Status
- UNKNOWN
- Phase
- PHASE4
Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Efficacy and Safety Study of First-line Treatment With SG001 Plus Chemotherapy ± Bevacizumab Versus Placebo Plus Chemotherapy ±Bevacizumab for Recurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS≥1)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Immune Profile Selection By Fraction of ctDNA in Patients With Advanced NSCLC Treated With Immunotherapy
- Status
- RECRUITING
- Phase
- PHASE2
A Trial Comparing Chemotherapy Versus Novel Immune Checkpoint Inhibitor (Pembrolizumab) Plus Chemotherapy in Treating Relapsed/Refractory Classical Hodgkin Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE3
A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Pemetrexed-free vs. Pemetrexed-based Immunochemotherapy in Metastatic TTF-1 Negative Lung Adenocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
DUMAS: Neo-Adjuvant Immunotherapy for Pancoast Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
JS004 Combined With Toripalimab and With Standard Chemotherapy Treat Patients With Advanced Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pyrotinib Combined With Trastuzumab, Dalpiciclib, Letrozole Versus TCbHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HR +/HER2 + Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study of AK119 and AK112 With or Without Chemotherapy for NSCLC Patients
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Novel Treatment Combinations in Patients With Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2